Filing Details

Item 3 is hereby amended and restated to read as follows: The Reporting Persons acquired 9,383,969 of the Shares reported owned herein pursuant to the Purchase Agreement (as defined in the Schedule 13D) in connection with the Private Placement (as defined in the Schedule 13D) and upon the exercise of the Pre-Funded Warrants acquired pursuant to the Purchase Agreement in connection with the Private Placement. As of the date hereof, the Reporting Persons are deemed to beneficially own the Shares as detailed in Item 5. The aggregate purchase price of the 438,247 Shares acquired by 325 Master Fund pursuant to the Purchase Agreement is approximately $701,195 and the aggregate purchase price of the 1,043,621 Shares acquired by 325 Master Fund upon the exercise of the Pre-Funded Warrants held by it is approximately $1,669,794 (inclusive of the price of the Pre-Funded Warrants and exclusive of brokerage commissions and other costs of execution). The aggregate purchase price of the 2,334,314 Shares acquired by the SMAs pursuant to the Purchase Agreement is approximately $3,734,902 and the aggregate purchase price of the 5,558,818 Shares acquired by the SMAs upon the exercise of the Pre-Funded Warrants held by them is approximately $8,894,109 (inclusive of the price of the Pre-Funded Warrants and exclusive of brokerage commissions and other costs of execution). The source of funding for the transactions pursuant to which the Reporting Persons obtained ownership of the Shares referenced above was derived from the working capital of 325 Master Fund and the SMAs (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business). 33,636 of the Shares reported owned herein were granted to Mr. Friedberg in connection with his service as a director of the Issuer.

Item 5(a) is hereby amended and restated to read as follows: As of the close of business on May 1, 2025, the Reporting Persons beneficially owned an aggregate of 9,408,636 Shares, which represents approximately 28.2% of the outstanding Shares, based upon 33,337,581 Shares outstanding as of April 15, 2025, as reported in the Issuer's Definitive Proxy Statement on Schedule 14A filed with the SEC on April 25, 2025. The aggregate beneficial ownership reflected in the remainder of this Item 5, and in the cover pages, reflect beneficial ownership as of the close of business on May 1, 2025.

Item 5(b) is hereby amended and restated to read as follows: Sole power to vote or direct the vote: 0 Shared power to vote or direct the vote: 9,408,636 Sole power to dispose or to direct the disposition: 0 Shared power to dispose or direct the disposition: 9,408,636 The power to vote or to direct the vote or to dispose or direct the disposition of the Shares reported herein is shared among the Reporting Persons, including the 7,893,132 Shares held in the SMAs and the 33,636 Shares granted to Mr. Friedberg in connection with his service as a director of the Issuer.

Item 5(c) is hereby amended and restated to read as follows: Other than as set forth in Item 6 below, the Reporting Persons have not entered into any transactions in the Shares during the past sixty days.

Item 6 is hereby amended to add the following: 325 and the Issuer have executed a waiver (the "Waiver") with respect to the Purchase Agreement (as defined in the Schedule 13D). Pursuant to the Waiver, to the extent any equity awards ("Director Equity") are issued to Mr. Friedberg in connection with his service as a director of the Issuer, the acquisition of beneficial ownership by 325 and any of its affiliates of such Director Equity pursuant to the Director Agreement (as defined below) shall not contribute or be counted towards the 35% percent thresholds set forth in Section 4.5, Section 4.21 and Section 4.22 of the Purchase Agreement. Mr. Friedberg and 325 have entered into an agreement (the "Director Agreement") with respect to any Director Equity awarded to him in his capacity as a director of the Issuer. Pursuant to the Director Agreement, any Director Equity awarded to Mr. Friedberg in his capacity as a director of the Issuer will be held by Mr. Friedberg on behalf of 325 or its affiliates, transferred by Mr. Friedberg to 325 or its affiliates, and/or sold by Mr. Friedberg, with the proceeds of such sale to be remitted to 325 or its affiliates, in each case as directed by 325. On April 28, 2025, Mr. Friedberg was granted 24,667 fully vested restricted stock units in connection with his service as a director of the Issuer, each representing the right to receive one Share.